217 related articles for article (PubMed ID: 32700438)
1. A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area.
Chapelle N; Petryszyn P; Blin J; Leroy M; Le Berre-Scoul C; Jirka I; Neunlist M; Moussata D; Lamarque D; Olivier R; Tougeron D; Mosnier JF; Matysiak-Budnik T
Helicobacter; 2020 Oct; 25(5):e12727. PubMed ID: 32700438
[TBL] [Abstract][Full Text] [Related]
2. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
Koivurova OP; Koskela R; Blomster T; Ala-Rämi A; Lumme H; Kettunen O; Hukkanen J; Karttunen TJ; Mäkinen M; Ronkainen J; Syrjänen K
Anticancer Res; 2021 Nov; 41(11):5527-5537. PubMed ID: 34732423
[TBL] [Abstract][Full Text] [Related]
3. GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia.
Masci E; Pellicano R; Mangiavillano B; Luigiano C; Stelitano L; Morace C; Viale E; Freschi M; Locatelli M; Ieri R; Cavallaro A; Testoni S; Testoni PA
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):79-83. PubMed ID: 24632770
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
[TBL] [Abstract][Full Text] [Related]
5. [Serological diagnosis of atrophic gastritis with a combination of pepsinogen I and II, gastrin-17 and anti-Helicobacter pylori antibodies].
Valle Muñoz J; Artaza Varasa T; López Pardo R; Rodríguez Merlo R; Pérez Grueso MJ; Martín Escobedo R; Alcántara Torres M; Cuena Boy R; Carrobles Jiménez JM
Gastroenterol Hepatol; 2007 Dec; 30(10):567-71. PubMed ID: 18028850
[TBL] [Abstract][Full Text] [Related]
6.
MÄki M; SÖderstrÖm D; Paloheimo L; Hendolin P; Suovaniemi O; SyrjÄnen K
Anticancer Res; 2020 Nov; 40(11):6387-6398. PubMed ID: 33109577
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of GastroPanel for the diagnosis of atrophic gastritis.
McNicholl AG; Forné M; Barrio J; De la Coba C; González B; Rivera R; Esteve M; Fernandez-Bañares F; Madrigal B; Gras-Miralles B; Perez-Aisa A; Viver-Pi-Sunyer JM; Bory F; Rosinach M; Loras C; Esteban C; Santolaria S; Gomollon F; Valle J; Gisbert JP;
Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):941-8. PubMed ID: 25014624
[TBL] [Abstract][Full Text] [Related]
8. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.
Iijima K; Abe Y; Kikuchi R; Koike T; Ohara S; Sipponen P; Shimosegawa T
World J Gastroenterol; 2009 Feb; 15(7):853-9. PubMed ID: 19230047
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K
Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
[TBL] [Abstract][Full Text] [Related]
11. Is GastroPanel serum assay useful in the diagnosis of Helicobacter pylori infection and associated gastritis in children?
Koivusalo AI; Pakarinen MP; Kolho KL
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):35-8. PubMed ID: 16949782
[TBL] [Abstract][Full Text] [Related]
12. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.
Hartleb M; Wandzel P; Waluga M; Matyszczyk B; Bołdys H; Romañczyk T
Acta Gastroenterol Belg; 2004; 67(4):320-6. PubMed ID: 15727075
[TBL] [Abstract][Full Text] [Related]
13. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.
Agréus L; Kuipers EJ; Kupcinskas L; Malfertheiner P; Di Mario F; Leja M; Mahachai V; Yaron N; van Oijen M; Perez Perez G; Rugge M; Ronkainen J; Salaspuro M; Sipponen P; Sugano K; Sung J
Scand J Gastroenterol; 2012 Feb; 47(2):136-47. PubMed ID: 22242613
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performances of pepsinogens and gastrin-17 for atrophic gastritis and gastric cancer in Mongolian subjects.
Dondov G; Amarbayasgalan D; Batsaikhan B; Badamjav T; Batbaatar B; Tuvdenjamts B; Tumurbat N; Davaa B; Purevdorj E; Nyamaa B; Lonjid T
PLoS One; 2022; 17(10):e0274938. PubMed ID: 36251649
[TBL] [Abstract][Full Text] [Related]
15. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.
Väänänen H; Vauhkonen M; Helske T; Kääriäinen I; Rasmussen M; Tunturi-Hihnala H; Koskenpato J; Sotka M; Turunen M; Sandström R; Ristikankare M; Jussila A; Sipponen P
Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):885-91. PubMed ID: 12867799
[TBL] [Abstract][Full Text] [Related]
16. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
17. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis.
Zagari RM; Rabitti S; Greenwood DC; Eusebi LH; Vestito A; Bazzoli F
Aliment Pharmacol Ther; 2017 Oct; 46(7):657-667. PubMed ID: 28782119
[TBL] [Abstract][Full Text] [Related]
18. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
19. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
20. Are the serum biomarkers pepsinogen I and II good predictors for the detection of subjects with atrophic gastritis in areas that have different gastric cancer incidence?
Mohamadkhani A; Darvish Moghaddam S; Salmanroghani H; Allafsghari A; Yazdanbod A; Mirzaei M; Haj-sheykholeslami A; Bashiri J; Sadjadi A; Massarrat S
Arch Iran Med; 2013 Apr; 16(4):208-12. PubMed ID: 23496362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
